Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,445.80    -5.60 (-0.39%)
Bid:
1,451.60
Ask:
1,452.00
Spread: 0.40 (0.028%)
Market Cap: £247.93b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Pre Stabilisation Notice

17 Jun 2026 10:08

RNS Number : 6672I
HSBC Holdings PLC
17 June 2026
 

17th June 2026

Zurich Finance (Ireland) DAC

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice that no stabilisation was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

The securities:

Issuer:

Zurich Finance (Ireland) DAC

Guarantor (if any):

Zurich Insurance Company Ltd

Aggregate nominal amount:

USD 500m WNG

Description:

7-year Senior Unsecured

Offer price:

T +100bps area

Other offer terms:

Stabilisation:

Stabilising Manager(s):

Citi (B&D), HSBC, UBS

Stabilisation period expected to start on:

17th June 2026

Stabilisation period expected to end no later than:

18th July 2026

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAUBRKRNNUNARR
Date   Source Headline
8th Apr 20246:10 pmRNSTransaction in Own Shares
5th Apr 202410:00 amRNSDirector Declaration
4th Apr 20246:24 pmRNSTransaction in Own Shares
3rd Apr 20246:14 pmRNSTransaction in Own Shares
2nd Apr 20245:59 pmRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSCompletion of the sale of HSBC Bank Canada to RBC
28th Mar 20246:01 pmRNSTransaction in Own Shares
28th Mar 20244:30 pmRNSDirector/PDMR Shareholding
28th Mar 20244:00 pmRNSTotal Voting Rights
27th Mar 20245:58 pmRNSTransaction in Own Shares
27th Mar 20243:45 pmRNSPublication of base prospectus
26th Mar 20245:54 pmRNSTransaction in Own Shares
25th Mar 20245:58 pmRNSTransaction in Own Shares
22nd Mar 20245:50 pmRNSTransaction in Own Shares
22nd Mar 20242:00 pmRNSIssuance of subordinated unsecured notes
22nd Mar 202410:00 amRNS2024 AGM - Documents available at NSM
21st Mar 20246:03 pmRNSTransaction in Own Shares
21st Mar 202411:00 amRNSIssuance of subordinated unsecured notes
20th Mar 20245:51 pmRNSTransaction in Own Shares
20th Mar 202410:00 amRNSHong Kong Waiver-Contingent Convertible Securities
19th Mar 20245:46 pmRNSTransaction in Own Shares
19th Mar 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
18th Mar 20245:54 pmRNSTransaction in Own Shares
18th Mar 202411:20 amRNSPre Stabilisation Notice
15th Mar 20246:20 pmRNSTransaction in Own Shares
14th Mar 20246:07 pmRNSTransaction in Own Shares
14th Mar 20245:02 pmRNSDirector/PDMR Shareholding
13th Mar 20246:20 pmRNSTransaction in Own Shares
13th Mar 20244:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:06 pmRNSTransaction in Own Shares
12th Mar 202411:00 amRNSIssuance of subordinated unsecured notes
11th Mar 20245:56 pmRNSTransaction in Own Shares
8th Mar 20246:19 pmRNSTransaction in Own Shares
7th Mar 20246:05 pmRNSTransaction in Own Shares
6th Mar 20245:57 pmRNSTransaction in Own Shares
5th Mar 20245:48 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
4th Mar 20243:30 pmRNSIssuance of senior unsecured notes
1st Mar 20246:02 pmRNSTransaction in Own Shares
29th Feb 20245:52 pmRNSTransaction in Own Shares
29th Feb 20244:31 pmRNSDirector/PDMR Shareholding
29th Feb 20244:30 pmRNSTotal Voting Rights
28th Feb 20245:55 pmRNSTransaction in Own Shares
28th Feb 202411:01 amRNSDirector/PDMR Shareholding
28th Feb 202411:00 amRNSOverseas Regulatory Announcement - Grant of Awards
27th Feb 20245:56 pmRNSTransaction in Own Shares
26th Feb 20245:50 pmRNSTransaction in Own Shares
23rd Feb 20246:05 pmRNSTransaction in Own Shares
23rd Feb 20244:35 pmRNSDocuments available at NSM
23rd Feb 20244:20 pmRNSPublication of base prospectus supplement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.